Presence of mitogen-activated protein kinase in retinal Müller cells and its neuroprotective effect ischemia-reperfusion injury

Hiroshi Akiyama; Toru Nakazawa; Masahiko Shimura; Hiroshi Tomita; Makoto Tamai

doi:10.1097/00001756-200211150-00022

Presence of mitogen-activated protein kinase in retinal Müller cells and its neuroprotective effect ischemia-reperfusion injury

Hiroshi Akiyama, Toru Nakazawa, Masahiko Shimura, Hiroshi Tomita, Makoto Tamai

MED - Medical Sciences

Research output: Contribution to journal › Article › peer-review

38 Citations (Scopus)

Abstract

The purpose of this study was to determine whether the mitogen-activated protein kinase (MAPK) signaling pathway in the retina plays a neuroprotective role against ischemia-reperfusion injury. Western blot analysis showed that the MAPK activity was markedly increased within an hour after ischemia-reperfusion and subsequently decreased. Immunohistochemical studies revealed that MAPK was expressed mainly in the retinal Müller cells (RMCs). Pre-ischemic intravitreal administration of a MAPK inhibitor, U0126, increased the number of ganglion cell deaths induced by ischemia-reperfusion injury. We conclude that the MAPK activated in the RMCs protects ganglion cells against the ischemia-reperfusion injury through glia-neuronal interaction.

Original language	English
Pages (from-to)	2103-2107
Number of pages	5
Journal	NeuroReport
Volume	13
Issue number	16
DOIs	https://doi.org/10.1097/00001756-200211150-00022
Publication status	Published - 2002 Nov 15

Keywords

Ischemia-reperfusion
Neuroprotection
Retinal Müller cells
Retinal ganglion cell

ASJC Scopus subject areas

Neuroscience(all)

Access to Document

10.1097/00001756-200211150-00022

Cite this

@article{aba8d59f92774aa4ba48e90ccfe10de5,

title = "Presence of mitogen-activated protein kinase in retinal M{\"u}ller cells and its neuroprotective effect ischemia-reperfusion injury",

abstract = "The purpose of this study was to determine whether the mitogen-activated protein kinase (MAPK) signaling pathway in the retina plays a neuroprotective role against ischemia-reperfusion injury. Western blot analysis showed that the MAPK activity was markedly increased within an hour after ischemia-reperfusion and subsequently decreased. Immunohistochemical studies revealed that MAPK was expressed mainly in the retinal M{\"u}ller cells (RMCs). Pre-ischemic intravitreal administration of a MAPK inhibitor, U0126, increased the number of ganglion cell deaths induced by ischemia-reperfusion injury. We conclude that the MAPK activated in the RMCs protects ganglion cells against the ischemia-reperfusion injury through glia-neuronal interaction.",

keywords = "Ischemia-reperfusion, Neuroprotection, Retinal M{\"u}ller cells, Retinal ganglion cell",

author = "Hiroshi Akiyama and Toru Nakazawa and Masahiko Shimura and Hiroshi Tomita and Makoto Tamai",

year = "2002",

month = nov,

day = "15",

doi = "10.1097/00001756-200211150-00022",

language = "English",

volume = "13",

pages = "2103--2107",

journal = "NeuroReport",

issn = "0959-4965",

publisher = "Lippincott Williams and Wilkins",

number = "16",

}

TY - JOUR

T1 - Presence of mitogen-activated protein kinase in retinal Müller cells and its neuroprotective effect ischemia-reperfusion injury

AU - Akiyama, Hiroshi

AU - Nakazawa, Toru

AU - Shimura, Masahiko

AU - Tomita, Hiroshi

AU - Tamai, Makoto

PY - 2002/11/15

Y1 - 2002/11/15

N2 - The purpose of this study was to determine whether the mitogen-activated protein kinase (MAPK) signaling pathway in the retina plays a neuroprotective role against ischemia-reperfusion injury. Western blot analysis showed that the MAPK activity was markedly increased within an hour after ischemia-reperfusion and subsequently decreased. Immunohistochemical studies revealed that MAPK was expressed mainly in the retinal Müller cells (RMCs). Pre-ischemic intravitreal administration of a MAPK inhibitor, U0126, increased the number of ganglion cell deaths induced by ischemia-reperfusion injury. We conclude that the MAPK activated in the RMCs protects ganglion cells against the ischemia-reperfusion injury through glia-neuronal interaction.

AB - The purpose of this study was to determine whether the mitogen-activated protein kinase (MAPK) signaling pathway in the retina plays a neuroprotective role against ischemia-reperfusion injury. Western blot analysis showed that the MAPK activity was markedly increased within an hour after ischemia-reperfusion and subsequently decreased. Immunohistochemical studies revealed that MAPK was expressed mainly in the retinal Müller cells (RMCs). Pre-ischemic intravitreal administration of a MAPK inhibitor, U0126, increased the number of ganglion cell deaths induced by ischemia-reperfusion injury. We conclude that the MAPK activated in the RMCs protects ganglion cells against the ischemia-reperfusion injury through glia-neuronal interaction.

KW - Ischemia-reperfusion

KW - Neuroprotection

KW - Retinal Müller cells

KW - Retinal ganglion cell

UR - http://www.scopus.com/inward/record.url?scp=0037113280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037113280&partnerID=8YFLogxK

U2 - 10.1097/00001756-200211150-00022

DO - 10.1097/00001756-200211150-00022

M3 - Article

C2 - 12438934

AN - SCOPUS:0037113280

VL - 13

SP - 2103

EP - 2107

JO - NeuroReport

JF - NeuroReport

SN - 0959-4965

IS - 16

ER -

Presence of mitogen-activated protein kinase in retinal Müller cells and its neuroprotective effect ischemia-reperfusion injury

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this